Skip to content

Clinical trials

Gastrointestinal Neoplasms trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Country / region: Singapore Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20121
20161
20172
20201
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Recruiting2
Unknown status2
Active, not recruiting1
Approved for marketing1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National University Hospital, Singapore2
Haematology-Oncology1
Hoffmann-La Roche1
Pfizer1
Revolution Medicines, Inc.1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
Sumitomo Pharma America, Inc.1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms9
Neoplasms5
Intestinal Neoplasms4
Neoplasms by Site4
Bronchial Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Colonic Diseases3
Colonic Neoplasms3
Colorectal Neoplasms3
Digestive System Neoplasms3

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.